About this trial
After obtaining informed consent from the patients, all the medical history and treatment records of the patients who underwent gastroscopy since the onset of the disease, as well as gastric fluid samples, including laboratory and imaging data, were collected and recorded. The medical history and treatment records and gastric fluid samples were analyzed.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Patients underwent gastroscopy and treatment at the Endoscopy Center of Beijing Friendship Hospital, Capital Medical University, and received pathological biopsy.
Previous gastroscopy suggested the possibility of lesions.
No previous history of gastrointestinal cancer.
Disqualifiers
Patients could not cooperate with the examination or had contraindications to endoscopy.
Previous history of gastrointestinal tumors, gastrointestinal surgery, physical and chemical injuries of the gastrointestinal tract.
Severe bile reflux.
Take simethicone and other defoaming agents before examination.
Trial population
Gastric cancer and non-cancer patients
Trial design
Cohort
Prospective
Treatments tested in this trial
In vitro surface plasmon resonance detection
Diagnostic testGastric juice from patients was removed for isolation of extracellular vesicles and surface plasmon resonance detection in vitro
Treatment groups
Trial outcomes
Primary outcomes
Surface plasmon resonance(SPR) detection of extracellular vesicles in gastric juice of patients with gastric cancer has large shift and spectral changes
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: